Arsenal Medical

We are proud of Upma Sharma, PhD for sharing her journey and growth as CEO of Arsenal Medical.?A big thank you to MedExecWomen for being a powerful advocate and resource in advancing and inspiring women leaders in MedTech. ? #MedTech #WomeninMedTech

New Research Alert! Our latest manuscript on ResQFoam? has been published in Trauma Surgery and Acute Care Open! ResQFoam is an injectable, rapidly expanding, hydrophobic foam designed for life-threatening trauma. This latest work, supported by the National Institute of General Medical Sciences (NIGMS) demonstrates that ResQFoam, when injected into the intra-abdominal space, significantly improves survival in an otherwise lethal pre-clinical model of pelvic hemorrhage with complex pelvic fracture.?This is the fourth lethal pre-clinical model where the application of ResQFoam has improved survival! Check out our publication here: https://lnkd.in/e2WCXinu Upma Sharma, PhD #ResQFoam #HemorrhageControl #MedicalInnovation?

Today we announced the complete enrollment of an initial cohort of 10 patients in the EMBO-02 clinical study of NeoCast? to treat chronic subdural hematoma (cSDH). This key milestone has been achieved across three clinical sites in Australia, marking significant progress in our goal to transform the cSDH treatment landscape. ? Learn more about NeoCast, our next-generation, non-adhesive, solvent-free, liquid embolic material designed for deep distal penetration for middle meningeal embolization for conditions such as cSDH treatment. Learn more: https://lnkd.in/gJdvUwHK ? #Biomaterials #Neurovascular #ISC25

We're Hiring! Join our Team! If you are passionate about innovation and making an impact, we have an opportunity for a Senior Quality Assurance Engineer. Visit here to learn more: https://lnkd.in/eEwcxGKj

Today, we announced the initiation of the EMBO-02 clinical study of NeoCast? to treat chronic subdural hematomas (cSDH). EMBO-02 will enroll up to 10 subjects at three sites in Australia, and the first patient has already been enrolled at Monash Health. Learn more about NeoCast, a first-of-its-kind, shear-responsive, non-adhesive, solvent-free, liquid #embolic material designed for deep distal penetration: https://lnkd.in/gF54fWXV ? #Biomaterials #Neurovascular Lee-Anne Slater

We are honored to be among a fantastic group of finalists for the 2024 MedTech Innovator Mid-Stage Competition. If you plan to attend the MedTech Strategist Innovation Summit in San Diego, please reach out to set up a time or come and see our CEO, Upma Sharma, PhD, present the Arsenal story on November 20th. ?#InnovationSanDiego

We are excited to share that our CEO, Upma Sharma, PhD, will participate in two powerhouse panels at The MedTech Conference this week. #MTC24 #MedTechCon

We are grateful to Dr. Laetitia de Villiers for presenting NeoCast’s first-in-human results at our first WFITN Congress. Gold Coast University Hospital, Jeffrey Groom II, Upma Sharma, PhD WFITN NEW YORK #biomaterials #NeoCast

We are pleased to be featured in the MD+DI Let's Talk Medtech podcast. Learn more about our story from our CEO, Upma Sharma, PhD.

Thanks to MedTech Innovator and to the Arsenal Team who worked to create our video. Upma Sharma, PhD PhD Jeffrey Groom II Quynh Pham #MTIBestVideo